CC BY-NC-ND 4.0 · Asian J Neurosurg 2023; 18(02): 366-371
DOI: 10.1055/s-0043-1768603
Case Report

Mature Teratoma with Somatic-Type Malignancy: An Entity of Unacquaintance—A Case Report

Batuk Diyora
1   Department of Neurosurgery, LTMG Hospital, Mumbai, Maharashtra, India
,
Kavin Devani
1   Department of Neurosurgery, LTMG Hospital, Mumbai, Maharashtra, India
,
Sridhar Epari
2   Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Tata Memorial Hospital and ACTREC, Mumbai, Maharashtra, India
,
Gauri Deshpande
2   Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Tata Memorial Hospital and ACTREC, Mumbai, Maharashtra, India
,
Anup Purandare
1   Department of Neurosurgery, LTMG Hospital, Mumbai, Maharashtra, India
,
Ravi Wankhade
1   Department of Neurosurgery, LTMG Hospital, Mumbai, Maharashtra, India
› Author Affiliations

Abstract

Primary intracranial teratomas are nongerminomatous germ cell tumors. They are infrequent lesions along the craniospinal axis, with their malignant transformation extremely uncommon. A 50-year-old-male patient presented with one episode of generalized tonic–clonic seizure (GTCS), without any neurological deficit. Radiological imaging revealed a large lesion in the pineal region. He underwent gross total excision of the lesion. Histopathological examination was representative of teratoma with adenocarcinomatous malignant transformation. He underwent adjuvant radiation therapy and had an excellent clinical outcome. The present case highlights the rarity of malignant transformation of the primary intracranial mature teratoma.

Informed Consent

Patient's informed consent was obtained for this study.




Publication History

Article published online:
07 June 2023

© 2023. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Georgiu C, Opincariu I, Cebotaru CL. et al. Intracranial immature teratoma with a primitive neuroectodermal malignant transformation: case report and review of the literature. Rom J Morphol Embryol 2016; 57 (04) 1389-1395
  • 2 Kong Z, Wang Y, Dai C, Yao Y, Ma W, Wang Y. Central nervous system germ cell tumors: a review of the literature. J Child Neurol 2018; 33 (09) 610-620
  • 3 Lee YH, Park EK, Park YS, Shim KW, Choi JU, Kim DS. Treatment and outcomes of primary intracranial teratoma. Childs Nerv Syst 2009; 25 (12) 1581-1587
  • 4 Ramamurthy B, Tandon PN. Textbook of Neurosurgery. New Delhi: BI Publications; 1992: 1034-1036
  • 5 Romić D, Raguž M, Marčinković P. et al. Intracranial mature teratoma in an adult patient: a case report. J Neurol Surg Rep 2019; 80 (01) e14-e17
  • 6 Zygourakis CC, Davis JL, Kaur G. et al. Management of central nervous system teratoma. J Clin Neurosci 2015; 22 (01) 98-104
  • 7 Ait Benali H, Lalya L, Allaoui M. et al. Extragonadal mixed germ cell tumor of the right arm: description of the first case in the literature. World J Surg Oncol 2012; 10: 69
  • 8 Rosenblum MK, Nakazato Y, Matsutani M. CNS germ cell tumors. In: Louis DN, Ohgaki H, Weistler OD, Cavenee WK. eds. WHO Classification of Tumors of the Central Nervous System. 4th ed.. Lyon: IARC; 2007: 198-204
  • 9 Kubota Y, Seki M, Kawai T. et al. Comprehensive genetic analysis of pediatric germ cell tumors identifies potential drug targets. Commun Biol 2020; 3 (01) 544
  • 10 Echevarría ME, Fangusaro J, Goldman S. Pediatric central nervous system germ cell tumors: a review. Oncologist 2008; 13 (06) 690-699
  • 11 Palmer RD, Foster NA, Vowler SL. et al. Malignant germ cell tumours of childhood: new associations of genomic imbalance. Br J Cancer 2007; 96 (04) 667-676
  • 12 Agrawal M, Uppin MS, Patibandla MR. et al. Teratomas in central nervous system: a clinico-morphological study with review of literature. Neurol India 2010; 58 (06) 841-846
  • 13 Mahajan S, Suri V, Sahu S, Sharma MC, Sarkar C. World Health Organization Classification of Tumors of the Central Nervous System 5th Edition (WHO CNS5): what's new?. Indian J Pathol Microbiol 2022; 65 (Supplement): S5-S13
  • 14 Kobayashi T, Lunsford LD. eds. Pineal Region Tumors. Diagnosis and Treatment Options. Progress in Neurological Surgery. Vol 23. Basel: Karger; 2009: 59-75
  • 15 Freilich RJ, Thompson SJ, Walker RW, Rosenblum MK. Adenocarcinomatous transformation of intracranial germ cell tumors. Am J Surg Pathol 1995; 19 (05) 537-544
  • 16 Selves J, Long-Mira E, Mathieu MC, Rochaix P, Ilié M. Immunohistochemistry for diagnosis of metastatic carcinomas of unknown primary site. Cancers (Basel) 2018; 10 (04) 108
  • 17 Zynger DL, McCallum JC, Luan C, Chou PM, Yang XJ. Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns. Histopathology 2010; 56 (06) 750-757
  • 18 Buetow PC, Smirniotopoulos JG, Done S. Congenital brain tumors: a review of 45 cases. AJR Am J Roentgenol 1990; 155 (03) 587-593
  • 19 Comiter CV, Kibel AS, Richie JP, Nucci MR, Renshaw AA. Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases. J Urol 1998; 159 (03) 859-863
  • 20 Matsutani M, Sano K, Takakura K. et al. Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg 1997; 86 (03) 446-455
  • 21 Ogawa K, Toita T, Nakamura K. et al. Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors: a multiinstitutional retrospective analysis of 41 patients. Cancer 2003; 98 (02) 369-376
  • 22 Kyritsis AP. Management of primary intracranial germ cell tumors. J Neurooncol 2010; 96 (02) 143-149